Home >  Registry
     
 
Protocol Registry Trial Results IFPMA Background Links
About this Registry

This registry serves as a global repository for information on ongoing Roche Pharmaceuticals Phase II to Phase IV clinical studies, Phase I studies in patients and Roche Diagnostics interventional studies on advanced diagnostic products.

For More Information 

Common Questions
More Frequently Asked Questions 
Overview of Clinical Trials 
Glossary of Terms 
Phase Definitions 
Field Definitions 
Roche Clinical Trial Global Policy 
Site Provided by Thomson CenterWatch

Trial information

PROBE Study: A Study of NT-Pro-Brain Natriuretic Peptide (NT-proBNP) Levels in Patients Hospitalized With Heart Failure

Status: Recruiting

Protocol number: P04M071

Sponsor: Roche Diagnostics

Company division: Diagnostic

Brief summary: This study will evaluate assessment of NT-proBNP levels before discharge on management and clinical outcomes in patients admitted with heart failure.

Study type: Interventional study

Condition: Heart Failure

Intervention type: Diagnostic Test

Intervention name: ELECSYS®proBNP

Inclusion criteria:

  • adult patients 18–80 years of age;
  • clinical heart failure

Exclusion criteria:

  • acute coronary syndrome;
  • severe stenotic valvular disease

Gender: Males or Females

Accepts healthy volunteers: No

Anticipated start date: July, 2004

Trial registration date: 09/23/2005

Date last updated: 9/29/2008


Link to trial result

This trial is being conducted at the following locations:

New Zealand

  • Christchurch

To contact Roche for more information on this trial please complete the email form below. Treatment decisions and/or suitability for a specific trial are decisions only your healthcare provider can make. If you are patient interested in any of the studies, please have your healthcare provider contact us via this website, and they will be provided with the relevant clinical trial information.

Country*
Are you a:*
Subject*
Last Name*
First Name*
Telephone
E-mail*

your email address is needed for us to reply